Floranex

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• acne [Insufficient Evidence]
• allergic rhinitis [Insufficient Evidence]
• aphthous ulcer (canker sores) [Insufficient Evidence]
• ARDS [Insufficient Evidence]
• asthma [Insufficient Evidence]
• atopic dermatitis (eczema) [Insufficient Evidence]
• atopic disease [Possibly Ineffective]
• bacterial vaginosis [Possibly Effective]
• bronchopulmonary dysplasia [Insufficient Evidence]
• cancer [Insufficient Evidence]
• candidiasis, vulvovaginal [Insufficient Evidence]
• cholestasis [Insufficient Evidence]
• C. difficile infection prevention [Insufficient Evidence]
• colic [Insufficient Evidence]
• common cold [Insufficient Evidence]
• constipation [Insufficient Evidence]
• critical illness (trauma) [Insufficient Evidence]
• denture stomatitis [Insufficient Evidence]
• depression [Insufficient Evidence]
• diabetes [Insufficient Evidence]
• diabetic nephropathy [Insufficient Evidence]
• diarrhea [Insufficient Evidence]
• diarrhea, antibiotic-associated [Possibly Effective]
• diarrhea, radiation-related [Insufficient Evidence]
• diarrhea, rotaviral [Insufficient Evidence]
• generalized anxiety disorder [Insufficient Evidence]
• hepatic encephalopathy [Insufficient Evidence]
• HIV/AIDS [Insufficient Evidence]
• HTN [Insufficient Evidence]
• hypercholesterolemia [Insufficient Evidence]
• H. pylori infection [Possibly Effective]
• IBS [Possibly Effective]
• inflammatory bowel disease [Insufficient Evidence]
• intraventricular hemorrhage [Insufficient Evidence]
• lactose intolerance [Insufficient Evidence]
• Lyme disease [Insufficient Evidence]
• metabolic syndrome [Insufficient Evidence]
• nausea/vomiting, pregnancy-induced [Insufficient Evidence]
• necrotizing enterocolitis [Insufficient Evidence]
• metabolic dysfunction-associated steatotic liver disease [Insufficient Evidence]
• metabolic dysfunction-associated steatohepatitis [Insufficient Evidence]
• obesity [Insufficient Evidence]
• polycystic ovary syndrome [Insufficient Evidence]
• postop infection [Insufficient Evidence]
• pouchitis, chronic [Insufficient Evidence]
• prematurity [Insufficient Evidence]
• psoriasis [Insufficient Evidence]
• respiratory infections [Insufficient Evidence]
• retinopathy of prematurity [Insufficient Evidence]
• rheumatoid arthritis [Insufficient Evidence]
• sepsis [Insufficient Evidence]
• short bowel syndrome [Insufficient Evidence]
• small intestinal bacterial overgrowth (SIBO) [Insufficient Evidence]
• traveler's diarrhea prophylaxis [Insufficient Evidence]
• ulcerative colitis [Insufficient Evidence]
• UTI prevention [Insufficient Evidence]
• ventilator-associated pneumonia prevention [Insufficient Evidence]